This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

25 Oct 2012

Flu jab market 'worth $3.8bn by 2018' in top seven countries

Growth is expected in the seasonal influenza vaccine market.


Pharmaceutical companies with influenza vaccines in their product portfolios are likely to enjoy a growth in revenues over the coming years, a new report suggests.

Related News